Fluctuating alertness—sudden shifts in attention, awareness, and wakefulness that can change within minutes or across a single day—is a hallmark sign of Lewy Body Dementia (LBD). When a person with LBD is alert and engaged one moment, then becomes drowsy or confused the next, or stares blankly for extended periods before snapping back to clarity, these changes aren’t random confusion or normal aging. They signal a specific pattern of brain damage caused by the buildup of alpha-synuclein, a toxic protein that disrupts the brain’s ability to maintain consistent mental function.
A person with LBD might carry on a coherent conversation at breakfast, seem entirely unreachable by mid-morning, and recover enough presence to watch television by evening—all without any obvious trigger like medication changes or infection. Fluctuating alertness appears in mild variations across many conditions, but in Lewy Body Dementia, these swings are pronounced enough to be one of the core diagnostic features. Doctors now recognize that pronounced, unpredictable fluctuations in attention and consciousness are not a sign of delirium caused by external factors like illness or medication, but rather a signature of how LBD damages the brain itself. Understanding this pattern matters because it changes how doctors evaluate symptoms, how families respond to day-to-day challenges, and what treatments might help.
Table of Contents
- What Does Fluctuating Alertness Actually Look Like in Lewy Body Dementia?
- How Fluctuating Alertness in LBD Differs from Alzheimer’s Disease and Other Dementias
- The Neurobiology Behind Fluctuating Alertness in Lewy Body Dementia
- How Doctors Diagnose LBD Based on Fluctuating Alertness
- What Recent Research Reveals About Fluctuating Alertness and Treatment
- How Common Is Lewy Body Dementia and Who Gets It?
- Managing Daily Life with Fluctuating Alertness: What Families Face
What Does Fluctuating Alertness Actually Look Like in Lewy Body Dementia?
Fluctuating alertness in LBD manifests as delirium-like changes in consciousness and attention that can shift dramatically—from moment to moment to day by day. A person might have periods of lethargy where they seem to withdraw into themselves, staring ahead without tracking conversations or movement around them. Then, without warning, they snap back into sharp awareness. Some people experience what clinicians call “on-and-off periods,” where they cycle between being engaged and being unreachable. These are not the gradual, steady decline seen in other dementias; they are abrupt transitions that catch families and caregivers off guard. The fluctuations often include incoherent thinking during the low periods.
Speech might become slurred or jumbled, and even once-simple decisions feel impossible. One family described their father spending the morning unable to find words or follow requests, then becoming articulate enough by afternoon to discuss his concerns about his health. By dinner, he had withdrawn again. This pattern—the unpredictability, the lack of a clear external cause—is what distinguishes LBD’s fluctuating alertness from the mental haze someone might experience with an infection or medication side effect. What makes this particularly challenging is that the fluctuations in alertness and the fluctuations in cognition operate independently. A person might be somewhat alert but unable to think clearly, or mentally sharp but so drowsy they can barely keep their eyes open. Neither symptom reliably predicts the other, which means caregivers cannot count on morning routines to stay the same from one day to the next.
How Fluctuating Alertness in LBD Differs from Alzheimer’s Disease and Other Dementias
The most important distinction is that Alzheimer’s disease typically causes a steady, progressive loss of memory and thinking ability—not the dramatic hour-to-hour or day-to-day fluctuations seen in LBD. An Alzheimer’s patient might grow increasingly forgetful and confused over weeks and months, but they do not experience the sudden drops in alertness or the temporary returns to near-normal function that define LBD. Memory loss, while present in LBD, is far less prominent than the fluctuating consciousness and attention problems. Families sometimes report that their relative with LBD remembers recent events reasonably well but cannot stay awake to participate in family events, or becomes too confused during waking periods to hold a conversation. LBD also brings symptoms that Alzheimer’s typically does not: vivid visual hallucinations (seeing people, animals, or objects that are not there), and Parkinsonian motor problems like a mask-like face, muscle rigidity, a shuffling gait, and balance difficulties.
These additional features, combined with the fluctuations in alertness, help doctors distinguish LBD from pure Alzheimer’s disease. However, the distinction is not always clear-cut. Approximately 50% of people with LBD also have the brain changes associated with Alzheimer’s disease. This overlap complicates diagnosis because a person might have memory loss from Alzheimer’s pathology combined with fluctuating alertness from alpha-synuclein. Some people live for years not knowing they have LBD because their symptoms were attributed to Alzheimer’s alone.
The Neurobiology Behind Fluctuating Alertness in Lewy Body Dementia
Fluctuating alertness in LBD stems from the accumulation of alpha-synuclein, a protein that misfolds and clumps together in neurons throughout the brain. In LBD, over 90% of these alpha-synuclein deposits gather at the presynaptic terminals—the sending ends of nerve connections—where they disrupt the normal release and reception of neurotransmitters. Neurotransmitters are the chemical messengers that allow brain cells to communicate. When alpha-synuclein interferes with their release, the brain’s ability to maintain steady attention, alertness, and thought processing breaks down.
The more widely these deposits spread through the brain, and the more they damage these critical communication hubs, the more severe and frequent the fluctuations become. One particularly important neurotransmitter system in LBD is the cholinergic system, which relies on the chemical acetylcholine to regulate attention and alertness. Researchers have found that in LBD patients who experience significant consciousness disturbances—those pronounced fluctuations in alertness—the high-affinity nicotinic receptors in the temporal cortex (a region critical for memory and attention) show 62% to 66% higher binding than in LBD patients without major consciousness problems. This finding suggests that the brain’s attempt to compensate for alpha-synuclein damage by increasing nicotinic receptor activity is linked directly to the severity of alertness fluctuations. It also points toward a potential avenue for treatment: medications or interventions that stabilize cholinergic function might help even out the fluctuations.
How Doctors Diagnose LBD Based on Fluctuating Alertness
Fluctuating alertness serves as a core diagnostic criterion for Probable Lewy Body Dementia. According to current diagnostic standards, a person must have dementia (memory, thinking, or behavioral problems that interfere with daily life) plus at least two core features—and one of the most important core features is fluctuating cognition with pronounced variations in attention and alertness—or at least one core feature plus one or more biomarkers (like specific findings on brain imaging). This means that if a person shows clear dementia combined with marked fluctuations in alertness, doctors have sufficient evidence to consider LBD as the likely diagnosis without requiring brain imaging or other advanced tests.
To measure and track these fluctuations in a standardized way, clinicians use the Clinician’s Assessment of Fluctuations, a validated tool that assesses the severity and frequency of alertness and attention changes. This tool has become the standard measure in clinical trials for LBD, allowing doctors and researchers to quantify what family members observe anecdotally—the good hours and bad hours, the days when the person seems present and the days when they are absent. Having a standardized measure is crucial because fluctuations can be subtle enough that they are missed, or so variable that without documentation, family members begin to doubt whether the pattern is real.
What Recent Research Reveals About Fluctuating Alertness and Treatment
Over the past year and a half, several clinical trials have begun targeting the mechanisms behind fluctuating alertness in LBD. Repetitive Transcranial Magnetic Stimulation (rTMS)—a non-invasive technique that uses magnetic pulses to stimulate brain activity—is currently being tested at University Hospital Strasbourg specifically for its effect on cognitive fluctuations. Another trial at the University of Michigan is investigating whether stimulating the cingulo-opercular network, a brain region involved in attention and consciousness, can help normalize alertness by addressing the underlying acetylcholine imbalances. These are not traditional medications but rather neuromodulation approaches that aim to restore more stable brain function.
On the pharmacological front, a Phase 2b trial of neflamapimod, a drug designed to improve cognition and mobility in LBD, completed in March 2026. Separately, Phase 2 trials of CT1812, a sigma-2 receptor antagonist, are underway, with the goal of helping the brain remove alpha-synuclein and beta-amyloid more effectively. These trials reflect a shift in LBD research away from merely managing symptoms and toward actually addressing the underlying pathology. However, it is important to recognize that most of these approaches remain experimental. Treatments available today—like cholinesterase inhibitors such as donepezil—can offer modest improvements in some symptoms but do not halt the progression of the disease or dramatically reduce fluctuations in alertness.
How Common Is Lewy Body Dementia and Who Gets It?
Lewy Body Dementia is the second most common neurodegenerative dementia after Alzheimer’s disease, yet it remains underdiagnosed because its symptoms overlap with other conditions and many physicians have limited familiarity with its specific presentation. Across incidence studies using consistent diagnostic criteria, LBD accounts for 3.2% to 7.1% of all diagnosed dementias. These estimates vary depending on the population studied and the diagnostic methods used, but the consistent finding is that LBD is far more common than many people realize.
Recent 2025 data from an Italian cohort study provides detailed incidence figures: the crude incidence of LBD was 3.56 per 100,000 person-years. Incidence peaks significantly in the oldest age groups, with rates of 18.58 per 100,000 person-years in women and 41.4 per 100,000 person-years in men ages 80 to 84. This means that while LBD can appear at younger ages, it becomes increasingly common in the very oldest segments of the population. For a family with a parent or grandparent in their eighties or nineties experiencing unexplained fluctuations in alertness, the odds that LBD is responsible are considerably higher than most people assume.
Managing Daily Life with Fluctuating Alertness: What Families Face
Families living with a loved one whose alertness fluctuates unpredictably face a unique set of challenges that differ markedly from managing other dementias. Because the person might be mentally sharp in the morning but nearly unreachable by afternoon, or vice versa, families cannot develop a consistent routine or predict when their loved one will be able to participate in activities, make decisions, or even recognize them. One son described the difficulty of trying to have important conversations with his mother about her wishes for care: on good days, she understood everything and could discuss her preferences clearly; on bad days, she did not retain the conversation at all. He eventually learned to document everything in writing and revisit conversations during her alert periods, knowing that the next fluctuation could erase recent memory and engagement.
Managing medication and medical care becomes more complicated with fluctuating alertness because distinguishing between medication side effects, disease progression, and normal fluctuations requires careful observation over time. A person might appear to have a bad reaction to a new blood pressure medication, but the symptoms might simply reflect one of their natural low-alertness periods. Close tracking—noting times of day, recent changes, and patterns—helps doctors and families make better decisions. It is equally important to recognize that the fluctuations themselves are part of the disease, not something that can be entirely eliminated with current treatments, so expectations must be adjusted accordingly to prevent frustration and burnout among caregivers.
